Tag Archives: Erbitux

New Hope for Patients with Advanced Metastatic Colorectal Cancer Patients

Colorectal cancer is the fourth most common cancer in men and women with nearly 500,000 deaths due to colorectal cancer every year.  When detected early at localized stage I, the 5-year survival rate can reach 90%. At this stage, surgical … Continue reading

Posted in Cancer, Colorectal cancer | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Cetuximab Increases Survival in Patients with Lung Cancer with High EGFR Expression

Good news for patients with non-small-cell lung cancer (NSCLC)!  If you have NSCLC, you might like to ask your oncologist to check whether you have high expression of EGFR.  Patients with high EGFR expression represented about 25 percent of people … Continue reading

Posted in Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , | Leave a comment

Cetuximab (Erbitux) Reduces Disease Progression in Triple Negative Breast Cancer

Patients with triple negative breast cancer usually have poor prognosis, but a new drug might soon be available to improve the survival in these patients.   Mid-stage study results presented at the European Society for Medical Oncology congress indicated that cetuximab(Erbitux) … Continue reading

Posted in Breast cancer, Cancer | Tagged , , , , , | Leave a comment